Clinical trial
STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation…
NCT00367757 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00367757 |
|---|---|
| Title | STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial |
| Official title | Open, Prospective, Randomized Trial Comparing Trigger vs Substrate vs Hybrid Approaches for AF Ablation |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Procedure |
| Interventions | Ablate AF triggers via PVI, Substrate via CFAEs, Combined approach for AF ablation |
| Enrollment | 107 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Aug 23, 2006 |
| Last update posted | Jan 30, 2019 |
| Countries | Canada, Italy, Norway, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: